Development of an oral treatment with the PPAR-γ-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson’s disease
Revista:
Molecules
ISSN: 1420-3049
Any de publicació: 2019
Volum: 24
Número: 15
Tipus: Article